Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) has shared an update.
Firebrick Pharma Limited has applied for quotation of 360,000 new fully paid ordinary shares on the ASX, with an issue date of April 13, 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments, modestly expanding the company’s listed share capital and providing additional liquidity for investors without indicating a major strategic shift or transaction.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australia-based pharmaceutical company listed on the ASX under the code FRE. The company operates in the healthcare sector, focusing on the development and commercialisation of pharmaceutical products, with its securities traded publicly to support ongoing operations and growth initiatives.
Average Trading Volume: 89,392
Technical Sentiment Signal: Sell
Current Market Cap: A$14.39M
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.